Skip to main content
رجوع
Watch Compare

Tonix Pharmaceuticals Holding Corp.

جودة البيانات: 100%
TNXP
Nasdaq Manufacturing Chemicals
KWD 12.48
▼ KWD 0.52 (-4.00%)
القيمة السوقية: 187.44 M
السعر
KWD 13.20
القيمة السوقية
187.44 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -103.21 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)29.85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-62.14%
أقل من متوسط القطاع (-53.41%)
ROIC-49.69%
Net Margin-946.22%
Op. Margin-959.05%

الأمان

Debt / Equity
0.04
أقل من متوسط القطاع (0.31)
Current Ratio9.89
Interest Coverage-1412.39

التقييم

PE (TTM)
-1.51
أقل من متوسط القطاع (-1.48)
P/B Ratio0.81
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.5 -1.5
P/B 0.8 1.6
ROE % -62.1 -53.4
Net Margin % -946.2 -41.5
Rev Growth 5Y % — 1.8
D/E 0.0 0.3

ETFs Holding This Stock

NOSGX NOSGX
0.20% weight
WINDX WINDX
0.03% weight
WFIVX WFIVX
0.03% weight
IRSSX IRSSX
0.01% weight
VVICX VVICX
0.01% weight
IIRSX IIRSX
0.01% weight
IRCIX IRCIX
0.01% weight
IRSIX IRSIX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 29.85% Revenue Growth (3Y) 29.90%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 13.11 M Net Income (TTM) -124.02 M
ROE -62.14% ROA -56.40%
Gross Margin N/A Operating Margin -959.05%
Net Margin -946.22% Free Cash Flow (TTM) -103.21 M
ROIC -49.69% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.04 Current Ratio 9.89
Interest Coverage -1412.39 Asset Turnover 0.06
Working Capital 187.04 M Tangible Book Value 231.02 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.51 Forward P/E N/A
P/B Ratio 0.81 P/S Ratio 14.30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55.06%
Market Cap 187.44 M Enterprise Value 6.04 M
Per Share
EPS (Diluted TTM) -14.57 Revenue / Share 0.92
FCF / Share -7.27 OCF / Share -7.03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 25.70% FCF Conversion 83.22%
SBC-Adj. FCF -108.48 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.11 M 10.09 M 7.77 M — —
Net Income -124.02 M -130.04 M -116.66 M -110.22 M -92.29 M
EPS (Diluted) -14.57 -176.60 -6.85 -3.27 —
Gross Profit — — — — —
Operating Income -125.70 M -136.70 M -118.38 M -112.09 M -92.31 M
EBITDA — — — — —
R&D Expenses 44.49 M 39.97 M 86.66 M 81.88 M 68.84 M
SG&A Expenses 87.68 M 40.10 M 34.75 M — —
D&A 1.93 M 3.42 M 4.29 M 1.25 M 50,000.0
Interest Expense 89,000.0 — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 277.17 M 162.89 M 154.46 M 225.69 M 240.90 M
Total Liabilities 32.02 M 23.33 M 48.93 M 18.51 M 22.18 M
Shareholders' Equity 245.15 M 139.56 M 105.53 M 207.18 M 218.72 M
Total Debt 8.65 M 8.65 M 11.00 M — —
Cash & Equivalents 207.64 M 98.78 M 24.95 M 120.23 M 178.66 M
Current Assets 228.88 M 119.00 M 47.77 M 130.78 M 189.05 M
Current Liabilities 30.84 M 18.31 M 18.88 M 18.18 M 21.72 M